Dabigatran Compared With Rivaroxaban vs Warfarin-Reply

Affiliations

¹ Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.
² Acumen LLC, Burlingame, California.
³ Centers for Medicare & Medicaid Services, Washington, DC.

Comment

David J Graham et al. JAMA Intern Med. 2017.

. 2017 May 1;177(5):743-744.

doi: 10.1001/jamainternmed.2017.0567.

¹ Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.
² Acumen LLC, Burlingame, California.
³ Centers for Medicare & Medicaid Services, Washington, DC.

No abstract available

Comment on

Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation.
Graham DJ, Reichman ME, Wernecke M, Hsueh YH, Izem R, Southworth MR, Wei Y, Liao J, Goulding MR, Mott K, Chillarige Y, MaCurdy TE, Worrall C, Kelman JA. Graham DJ, et al. JAMA Intern Med. 2016 Nov 1;176(11):1662-1671. doi: 10.1001/jamainternmed.2016.5954. JAMA Intern Med. 2016. PMID: 27695821
Dabigatran Compared With Rivaroxaban vs Warfarin.
Schwartz JB. Schwartz JB. JAMA Intern Med. 2017 May 1;177(5):741-742. doi: 10.1001/jamainternmed.2017.0554. JAMA Intern Med. 2017. PMID: 28460097 No abstract available.
Dabigatran Compared With Rivaroxaban vs Warfarin.
Vora AN, Alexander JH, Lopes RD. Vora AN, et al. JAMA Intern Med. 2017 May 1;177(5):742-743. doi: 10.1001/jamainternmed.2017.0561. JAMA Intern Med. 2017. PMID: 28460098 No abstract available.
Dabigatran Compared With Rivaroxaban vs Warfarin.
Zhao YJ, Lim WS. Zhao YJ, et al. JAMA Intern Med. 2017 May 1;177(5):742. doi: 10.1001/jamainternmed.2017.0564. JAMA Intern Med. 2017. PMID: 28460099 No abstract available.